Orikami

Nijmegen, Netherlands Founded: 2019 • Age: 7 yrs
Digital biomarkers are utilized for disease detection and measurement.
Request Access

About Orikami

Orikami is a company based in Nijmegen (Netherlands) founded in 2019.. Orikami has raised $654.49 thousand across 2 funding rounds from investors including CbusineZ and Healthy.Capital. Orikami offers products and services including Digital Biomarkers and Data Science Services. Orikami operates in a competitive market with competitors including MedWhat, Applied Pathways, GenID Solutions, Open Source Health and IEEARC, among others.

  • Headquarter Nijmegen, Netherlands
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $654.49 K (USD)

    in 2 rounds

  • Latest Funding Round
  • Investors
    CbusineZ

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Orikami

Orikami offers a comprehensive portfolio of products and services, including Digital Biomarkers and Data Science Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Objective data from digital devices for personalized healthcare decisions.

Utilizes patient data to optimize healthcare paths and outcomes.

Funding Insights of Orikami

Orikami has successfully raised a total of $654.49K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (02 Oct 2019)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2021 Amount Seed - Orikami Valuation

investors

Oct, 2019 Amount Seed - Orikami Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Orikami

Orikami has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include CbusineZ and Healthy.Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Healthy.Capital is focused on investing in digital health startups.
Founded Year Domain Location
Invests in and supports early stage healthcare innovations in Dutch sector.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Orikami

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Orikami

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Orikami Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Orikami

Orikami operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedWhat, Applied Pathways, GenID Solutions, Open Source Health and IEEARC, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
AI based personal medical assistant application
domain founded_year HQ Location
Offers a cloud-based platform for clinical rules modeling and enterprise knowledge management.
domain founded_year HQ Location
Delivers a clinical decision support tool for disease detection.
domain founded_year HQ Location
Online platform for women health assistance to deliver precision medicine.
domain founded_year HQ Location
Lifestyle diseases are monitored via cloud-based health analytics platform.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Orikami

Frequently Asked Questions about Orikami

When was Orikami founded?

Orikami was founded in 2019.

Where is Orikami located?

Orikami is headquartered in Nijmegen, Netherlands. It is registered at Nijmegen, Gelderland, Netherlands.

Who is the current CEO of Orikami?

Bram Den Teuling is the current CEO of Orikami.

Is Orikami a funded company?

Orikami is a funded company, having raised a total of $654.49K across 2 funding rounds to date. The company's 1st funding round was a Seed of $654.49K, raised on Oct 02, 2019.

What does Orikami do?

Orikami was founded in 2019 in Nijmegen, Netherlands, focusing on the healthcare sector. Software has been developed by the company to assist providers in measuring and quantifying diseases. This enables informed decision-making processes through digital biomarkers. Operations center on disease detection and assessment tools, with the domain orikami.ai serving as the primary online presence. Leadership is provided by CEO Bram Den Teuling.

Who are the top competitors of Orikami?

Orikami's top competitors include MedWhat, Khure Health and Lead Horse Technologies.

What products or services does Orikami offer?

Orikami offers Digital Biomarkers and Data Science Services.

Who are Orikami's investors?

Orikami has 2 investors. Key investors include CbusineZ, and Healthy.Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available